...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Not adding up!

https://www.globenewswire.com/news-release/2021/11/15/2334457/0/en/Zenith-and-Newsoara-Biopharma-Announce-Expanded-Licensing-and-Investment.html

 

So, why give it away at this price when:

1. You're at the advanced stage of development that you are with ZEN-3694?

2. You are expecting some jaw-dropping numbers over at Resverlogix with regards to the Covid-19 trial?

Again...not adding up!

 

 

2
Nov 15, 2021 11:40AM
2
Nov 15, 2021 12:43PM
2
Nov 15, 2021 01:17PM
3
Nov 15, 2021 01:46PM
2
Nov 15, 2021 02:05PM
3
Nov 15, 2021 02:21PM
1
Nov 15, 2021 04:05PM
3
Nov 15, 2021 09:09PM
1
Nov 16, 2021 09:53AM
3
Nov 16, 2021 12:02PM
4
Nov 16, 2021 12:18PM
6
Nov 16, 2021 03:37PM
Share
New Message
Please login to post a reply